Publication Date

2018-09-28

Availability

Open access

Embargo Period

2018-09-28

Degree Type

Dissertation

Degree Name

Doctor of Philosophy (PHD)

Department

Biochemistry and Molecular Biology (Medicine)

Date of Defense

2018-08-24

First Committee Member

Chaitanya Jain

Second Committee Member

Antoni Barrientos

Third Committee Member

Murray P. Deutscher

Fourth Committee Member

Carlos Moraes

Fifth Committee Member

Daniel Bogenhagen

Abstract

Mammalian mitochondrial ribosomes (mitoribosomes) synthesize thirteen proteins, essential components of the oxidative phosphorylation system. They are linked to mitochondrial disorders, often involving cardiomyopathy. Mitoribosome biogenesis is assisted by multiple cofactors whose specific functions remain largely uncharacterized. Here, we examined the role of human MTG1, a conserved ribosome assembly GTPase. MTG1-silencing in human cardiomyocytes and developing zebrafish revealed early cardiovascular lesions. A combination of gene-editing and biochemical approaches using HEK293T cells demonstrated that MTG1 binds to the large subunit (mtLSU) 16S rRNA to facilitate incorporation of late assembly proteins. Furthermore, MTG1 interacts with mtLSU uL19 protein and mtSSU mS27, a putative GTP-exchange factor (GEF), to enable MTG1 release and the formation of the mB6 intersubunit bridge. In this way, MTG1 establishes a quality control checkpoint in mitoribosome assembly. In conclusion, MTG1 controls mitochondrial translation by coupling mtLSU assembly with intersubunit bridge formation using the intrinsic GEF activity acquired by the mtSSU through mS27, a unique occurrence in translational systems.

Keywords

Mitochondria; mitoribosome; mitocondrial translation; mitochondrial diseases

Share

COinS